INTERCEPT PHARMACEUTICALS, INC.·4

Jun 23, 4:04 PM ET

Saik Andrew 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jun 23, 2023

Insider Transaction Report

Form 4
Period: 2023-06-21
Saik Andrew
EVP & Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-06-21$11.74/sh908$10,66069,173 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2319483-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT